文献速递真菌感染

超高效液相色谱法测定脂质体两性霉素B给药后血浆总两性霉素B浓度

Ultra-performance liquid chromatography for quantification of amphotericin B plasma concentrations after use of liposomal amphotericin B.
PubMed 文献 · J Antimicrob Chemother · 2021-01-01

本研究开发并验证了一种UPLC-PDA分析方法,用于定量脂质体两性霉素B给药后血浆中的总两性霉素B浓度,以支持其临床药代动力学研究。方法在0.5-50.0 mg/L范围内验证,准确度97.6%-112.1%,日内和日间精密度分别≤6.6%和≤4.6%。原计划分离脂质体与游离两性霉素B未能实现,但成功建立了总药物浓度的定量方法。

要点

  • UPLC-PDA法可定量脂质体两性霉素B给药后血浆总两性霉素B浓度。
  • 验证范围0.5-50.0 mg/L,准确度97.6%-112.1%,精密度良好。
  • 未能实现脂质体与游离两性霉素B的分离,仅测定总浓度。

核心结论

  • 成功开发并验证了UPLC-PDA方法,用于定量脂质体两性霉素B给药后血浆中的总两性霉素B浓度。

研究设计与样本

  • 方法学开发与验证研究,按照EMA要求验证线性、准确度、精密度、稀释完整性、残留、选择性和稳定性。

主要发现

  • 分析方法在0.5-50.0 mg/L浓度范围内验证。
  • 准确度范围为97.6%至112.1%。
  • 日内重复性为1.0%至6.6%,日间再现性为0.4%至4.6%,取决于浓度。
  • 原计划分离脂质体与游离两性霉素B未能实现。

关键数值与推荐

  • 验证浓度范围0.5-50.0 mg/L。
  • 准确度97.6%-112.1%。
  • 日内重复性1.0%-6.6%,日间再现性0.4%-4.6%。

临床怎么用

  • 该UPLC-PDA法可用于测定脂质体两性霉素B给药后血浆总两性霉素B浓度,支持临床药代动力学研究。

局限性

  • 未能分离脂质体和游离两性霉素B组分,仅能定量总药物浓度。
  • 脂质体两性霉素B的临床药代动力学数据仍缺乏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Liposomal amphotericin B is widely used to treat life-threatening invasive fungal infections and has replaced conventional amphotericin B deoxycholate due to its more favourable toxicity profile. Despite the fact that liposomal amphotericin B has been licensed for several decades, there is still a paucity of clinical pharmacokinetic data. An assay for the quantification of amphotericin B is necessary to allow the study of its pharmacokinetics. METHODS: A UPLC-photodiode array (PDA) analytical method was developed and validated (linearity, accuracy, precision, dilution integrity, carry-over, selectivity and stability) in accordance with EMA requirements. RESULTS: The analytical method was validated over a concentration range of 0.5-50.0 mg/L. Accuracy ranged from 97.6% to 112.1% and within-day repeatability and between-day reproducibility from 1.0% to 6.6% and from 0.4% to 4.6%, respectively, dependent on the concentration. Originally, the goal was to develop an analytical method to separate the liposomal and free amphotericin B fractions, but this was not achieved. Difficulties and bottlenecks encountered are presented. CONCLUSIONS: A UPLC-PDA analytical method was developed to quantify total amphotericin B in plasma after the use of liposomal amphotericin B.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Van Daele R, de Beer Y, Croes S, et al. Ultra-performance liquid chromatography for quantification of amphotericin B plasma concentrations after use of liposomal amphotericin B. J Antimicrob Chemother. 2021. PMID: 33351897. doi:10.1093/jac/dkaa515

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。